Accelerating Severe ME/CFS Research
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes on those suffering from severe ME/CFS symptoms and advocate for better research, support, and treatment. […]
Solve-Funded Phase 2 Observational Study Yields More Support for Repurposing Rapamycin to Reduce a Broad Range of ME/CFS Symptoms
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit organization that conducts research and observational studies on ME/CFS to find treatments for people with […]
Repurposing Rapamycin: A Report On the First Biomarker-Driven Treatment Trial for ME/CFS
In 2025, Simmaron Research was the second recipient of Solve’s ME/CFS Catalyst Award in support of its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” The […]
This Week in “What’s New in ME/CFS?” Dr. Avik Roy & Dr. Gunnar Gottschalk (Simmaron Research)
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do about this disease. Recently, we spoke with Dr. Avik Roy, Chief Scientific Officer at Simmaron […]
Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst […]
Exploring Current ME/CFS and Long COVID Clinical Trials on National Clinical Trials Day
May 20 is National Clinical Trials Day! When conducting clinical trials, researchers test how interventions (like behavioral changes, drugs, or medical devices) affect people. Usually, researchers carefully choose who takes […]
Hope Amid Uncertainty
A special message from Solve M.E. President and CEO Emily Taylor With so much speculation about the future, it’s easy to feel unsettled – and uncertainty is especially hard for […]